Erectile dysfunction oral film gets a lift from study

Thin films that dissolve in your mouth are not just for breath strips. Drug-delivery companies are sold on their ease of use and ability to release pharmaceutical compounds immediately. And Quebec-based IntelGenx is developing a thin oral film that delivers INT007, which is the bioequivalent to phosphodiesterase type 5 that is found in leading ED tablets Viagra and Cialis. IntelGenx has announced that it's finished a study that indicates its thin film might actually work faster than those leading ED tablets.

Its technology is called VersaFilm, and the study measured time to peak concentration, a common determinant of rate of absorption. The INT007 film achieved it 27 percent faster than oral tablets. That was enough to convince the company to start scale-up and manufacturing of batches required to support a clinical study and future filings for trials.

"The achievement of bioequivalence in this pilot study solidifies IntelGenx'[s] position at the forefront of immediate release film development," IntelGenx CEO Horst Zerbe says in a statement.

IntelGenx has a number of projects up its sleeve for its rapidly disintegrating films, including products for the treatment of pain, hypertension and depression.

- read the IntelGenx release
- check out Versafilm technology

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.